| Secondary |
| Osteoarthritis |
18.8% |
| Prophylaxis |
15.6% |
| Hiv Infection |
12.5% |
| Epilepsy |
9.4% |
| Gastritis |
6.3% |
| Hypertension |
6.3% |
| Pyrexia |
6.3% |
| Tuberculosis |
6.3% |
| Blood Cholesterol Increased |
3.1% |
| Cardiac Failure |
3.1% |
| Depression |
3.1% |
| Diabetes Mellitus |
3.1% |
| Dizziness |
3.1% |
| Gastrointestinal Carcinoma |
3.1% |
|
| Ischaemia |
25.0% |
| Metrorrhagia |
25.0% |
| Pyrexia |
25.0% |
| Rash |
25.0% |
|
| Concomitant |
| Product Used For Unknown Indication |
15.6% |
| Drug Use For Unknown Indication |
12.0% |
| Prophylaxis |
8.1% |
| Hiv Infection |
7.0% |
| Osteoarthritis |
5.8% |
| Rheumatoid Arthritis |
5.3% |
| Atrial Fibrillation |
5.0% |
| Hypertension |
5.0% |
| Multiple Myeloma |
4.7% |
| Tuberculosis |
4.5% |
| Premedication |
3.9% |
| Chronic Obstructive Pulmonary Disease |
3.1% |
| Menopause |
3.1% |
| Osteoporosis |
3.1% |
| Dyspnoea |
2.8% |
| Cardiac Disorder |
2.5% |
| Chronic Myeloid Leukaemia |
2.2% |
| Headache |
2.2% |
| Pain |
2.2% |
| Depression |
1.9% |
|
| Hepatitis Fulminant |
11.1% |
| Urinary Tract Infection |
9.5% |
| Urinary Incontinence |
7.9% |
| White Blood Cell Count Decreased |
6.3% |
| Arthralgia |
4.8% |
| Fatigue |
4.8% |
| Osteonecrosis |
4.8% |
| Polymyalgia Rheumatica |
4.8% |
| Rheumatoid Arthritis |
4.8% |
| Urinary Retention |
4.8% |
| Vaginal Infection |
4.8% |
| Vomiting |
4.8% |
| Weight Decreased |
4.8% |
| Alanine Aminotransferase Increased |
3.2% |
| Cardiac Arrest |
3.2% |
| Dyspnoea |
3.2% |
| Gastrointestinal Perforation |
3.2% |
| Headache |
3.2% |
| Ischaemic Stroke |
3.2% |
| Malignant Melanoma |
3.2% |
|
| Interacting |
| Depression |
20.0% |
| Hypercholesterolaemia |
20.0% |
| Hypertension |
20.0% |
| Osteoarthritis |
20.0% |
| Type 2 Diabetes Mellitus |
20.0% |
|
| Drug Interaction |
50.0% |
| Thrombocytopenia |
50.0% |
|
